홈 › 골수형성이상증후군 › 캘리포니아 › Baldwin Park
CA Baldwin Park의 골수형성이상증후군 임상 시험
골수형성이상증후군 관련 연구 26개가 Baldwin Park 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
피험자 모집 중1상
- City of Hope, Duarte · 4마일 거리
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
피험자 모집 중1/2상
- City of Hope - Duarte, Duarte · 4마일 거리
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
피험자 모집 중3상
- City of Hope - Comprehensive Cancer Center (CCC), Duarte · 4마일 거리
Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS
피험자 모집 중1상
- City of Hope National Medical Center, Duarte · 4마일 거리
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
피험자 모집 중3상
- City of Hope, Duarte · 4마일 거리
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
피험자 모집 중2상
- City of Hope National Medical Center, Duarte · 4마일 거리
Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome
피험자 모집 중2상
- City of Hope Medical Center, Duarte · 4마일 거리
225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
피험자 모집 중1상
- City of Hope Medical Center, Duarte · 4마일 거리
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
피험자 모집 중1상건강한 지원자 환영
- City of Hope Medical Center, Duarte · 4마일 거리
Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Donor Hematopoietic Cell Transplant
피험자 모집 중1상
- City of Hope Medical Center, Duarte · 4마일 거리
Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant
피험자 모집 중1상
- City of Hope Medical Center, Duarte · 4마일 거리
Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
피험자 모집 중2상
- City of Hope Medical Center, Duarte · 4마일 거리
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
피험자 모집 중1상
- City of Hope, Duarte · 4마일 거리
A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome
피험자 모집 중2상
- GSK Investigational Site, Duarte · 4마일 거리
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
피험자 모집 중
- Beckman Research Institute of City of Hope, Duarte · 4마일 거리
Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome
피험자 모집 중1상건강한 지원자 환영
- City of Hope Medical Center, Duarte · 4마일 거리
A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes
피험자 모집 중1상
- City of Hope Medical Center, Duarte · 4마일 거리
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
피험자 모집 중2상건강한 지원자 환영
- City of Hope Medical Center, Duarte · 4마일 거리
Olutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell Transplant
피험자 모집 중1상
- City of Hope Medical Center, Duarte · 4마일 거리
Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors
피험자 모집 중2상
- City of Hope Medical Center, Duarte · 4마일 거리
Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome
피험자 모집 중2상
- City of Hope Medical Center, Duarte · 4마일 거리
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
피험자 모집 중관찰 연구
- Massive Bio SYNERGY-AI site, Duarte · 4마일 거리
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
피험자 모집 중1상
- City of Hope Medical Center, Duarte · 4마일 거리
Study of REM-422 in Patients With AML or Higher Risk MDS
피험자 모집 중1상
- City of Hope, Duarte · 4마일 거리
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
피험자 모집 중1상
- City of Hope, Duarte · 4마일 거리
A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
피험자 모집 중1상
- City of Hope National Medical Center, Duarte · 4마일 거리
다른 도시의 골수형성이상증후군 시험
- Houston, TX연구 43개
- New York City, NY연구 21개
- Seattle, WA연구 21개
- Washington, DC연구 20개
- Tampa, FL연구 19개
- Boston, MA연구 19개
- Miami, FL연구 17개
- Durham, NC연구 14개
- Columbus, OH연구 14개
- St. Louis, MO연구 13개
- Atlanta, GA연구 13개
- Chicago, IL연구 13개
Baldwin Park의 다른 연구
- 유방암연구 44개
- 급성 골수성 백혈병연구 40개
- 대장직장암연구 37개
- 비소세포폐암연구 36개
- 암 (전체)연구 34개
- 전립선암연구 30개
- 전이성 암연구 30개
- 난소암연구 25개
- 폐암연구 24개
- 다발성 골수종연구 23개
- 위암연구 22개
- 급성 림프모구성 백혈병연구 21개
ClinicalTrials.gov 출처, 2026. 10. 6. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.